Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Paul Ceglia’s Facebook Case Is Nothing But a Media Circus

Paul Ceglia claimed he owns 50% of Facebook and sued Zuckerberg last year. The case naturally attracted a lot of media attention. Ceglia also hired Manhattan law firm DLA Piper and Buffalo firm Lippes Mathias Wexler Friedman. In April, DLA Piper made confident statements about the case. Here is an excerpt from a WSJ article:

Facebook Inc (FB), JetBlue Airways Corporation (JBLU)

On Tuesday, Mr. Ceglia’s new lawyer, Robert Brownlie, said before taking on the case he was skeptical of Mr. Ceglia’s claims and spent weeks investigating the claims and documents. He said he brought in an outside expert to examine the computer file used to create the contract and to verify when it was first created. He declined to identify the expert.

Mr. Brownlie said he hasn’t personally seen the original contract, but the more he studied the matter, he gained “absolutely 100% confidence that [Mr. Ceglia’s] agreement is authentic.”

Unfortunately, Ceglia’s legal team quit yesterday. This clearly implies that Ceglia has no real evidence to back up his claims. Court filings earlier this month showed that Ceglia doesn’t have any digital copies of emails between him and Zuckerberg. He has floppy disks with “copy-and-pasted” versions of those emails. This case has been nothing but a media circus. Facebook had maintained that the lawsuit is a fraud and the alleged contracts were all phony from the beginning.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!